On the public citation graph

Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer

0 signed · 466 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/eji.200838318openalex-snapshot
Hypoxia controls CD4+CD25+ regulatory T‐cell homeostasis via hypoxia‐inducible factor‐1α
inferredcites →https://doi.org/10.1007/s00018-015-2098-5openalex-snapshot
Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway
inferredcites →https://doi.org/10.1007/s00262-013-1434-6openalex-snapshot
Immune-suppressive properties of the tumor microenvironment
inferredcites →https://doi.org/10.1007/s10555-007-9054-2openalex-snapshot
Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues
inferredcites →https://doi.org/10.1007/s10620-006-9436-2openalex-snapshot
Involvement of Cyclooxygenase-2–Prostaglandin E2 Pathway in Interleukin-8 Production in Gastric Cancer Cells
inferredcites →https://doi.org/10.1016/0008-8749(87)90223-1openalex-snapshot
Regulation of T-cell functions by l-lactate
inferredcites →https://doi.org/10.1016/j.canlet.2015.10.026openalex-snapshot
miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function
inferredcites →https://doi.org/10.1016/j.ccr.2008.01.034openalex-snapshot
HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
inferredcites →https://doi.org/10.1016/j.ccr.2013.11.007openalex-snapshot
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
inferredcites →https://doi.org/10.1016/j.cell.2011.07.033openalex-snapshot
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
inferredcites →https://doi.org/10.1016/j.cell.2012.01.021openalex-snapshot
Hypoxia-Inducible Factors in Physiology and Medicine
inferredcites →https://doi.org/10.1016/j.ejmech.2012.01.033openalex-snapshot
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
inferredcites →https://doi.org/10.1016/j.imlet.2015.07.003openalex-snapshot
Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes
inferredcites →https://doi.org/10.1016/j.immuni.2015.05.016openalex-snapshot
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity
inferredcites →https://doi.org/10.1016/j.jhep.2015.08.008openalex-snapshot
Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection
inferredcites →https://doi.org/10.1016/j.tips.2012.01.005openalex-snapshot
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
inferredcites →https://doi.org/10.1016/s0002-9440(10)63483-9openalex-snapshot
Hypoxia-Induced Gene Expression in Human Macrophages
inferredcites →https://doi.org/10.1016/s0140-6736(15)01088-0openalex-snapshot
Antiangiogenic therapy in oncology: current status and future directions
inferredcites →https://doi.org/10.1016/s1470-2045(14)70189-5openalex-snapshot
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
inferredcites →https://doi.org/10.1038/bjc.2015.124openalex-snapshot
Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
inferredcites →https://doi.org/10.1038/jid.2013.115openalex-snapshot
Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching
inferredcites →https://doi.org/10.1038/nature10169openalex-snapshot
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
inferredcites →https://doi.org/10.1038/ni.2714openalex-snapshot
Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
inferredcites →https://doi.org/10.1038/nm.3394openalex-snapshot
Microenvironmental regulation of tumor progression and metastasis
inferredcites →https://doi.org/10.1038/nm.3541openalex-snapshot
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
inferredcites →https://doi.org/10.1038/nm1609openalex-snapshot
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
inferredcites →https://doi.org/10.1038/nrc3064openalex-snapshot
Targeting hypoxia in cancer therapy
inferredcites →https://doi.org/10.1038/nri2233openalex-snapshot
Creating immune privilege: active local suppression that benefits friends, but protects foes
inferredcites →https://doi.org/10.1038/sj.neo.7900190openalex-snapshot
Matrilysin [MMP-7] Expression Selects for Cells with Reduced Sensitivity to Apoptosis
inferredcites →https://doi.org/10.1056/nejmoa1504030openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1073/pnas.0915174107openalex-snapshot
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
inferredcites →https://doi.org/10.1073/pnas.1014519107openalex-snapshot
Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells
inferredcites →https://doi.org/10.1073/pnas.1202366109openalex-snapshot
Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
inferredcites →https://doi.org/10.1073/pnas.1304790110openalex-snapshot
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
inferredcites →https://doi.org/10.1074/jbc.m104782200openalex-snapshot
Differential Regulation of Two Alternatively Spliced Isoforms of Hypoxia-inducible Factor-1α in Activated T Lymphocytes
inferredcites →https://doi.org/10.1074/jbc.m115.651547openalex-snapshot
The Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing
inferredcites →https://doi.org/10.1080/15548627.2015.1017194openalex-snapshot
The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing
inferredcites →https://doi.org/10.1080/2162402x.2015.1048955openalex-snapshot
Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development
inferredcites →https://doi.org/10.1084/jem.20062512openalex-snapshot
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
inferredcites →https://doi.org/10.1084/jem.20100587openalex-snapshot
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
inferredcites →https://doi.org/10.1084/jem.20101956openalex-snapshot
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
inferredcites →https://doi.org/10.1084/jem.20110278openalex-snapshot
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
inferredcites →https://doi.org/10.1084/jem.20112607openalex-snapshot
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells
inferredcites →https://doi.org/10.1084/jem.20131916openalex-snapshot
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
inferredcites →https://doi.org/10.1093/annonc/mdr396openalex-snapshot
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
inferredcites →https://doi.org/10.1093/jnci/82.7.612openalex-snapshot
Lymphocytes Stimulated With Recombinant Human Interleukin-2: Relationship Between Motility Into Protein Matrix and In Vivo Localization in Normal and Neoplastic Tissues of Mice
inferredcites →https://doi.org/10.1093/neuonc/nou174.11openalex-snapshot
O2.04 * TREATMENT WITH OMX-4.80, A TUMOR-PENETRATING TUNABLE OXYGEN CARRIER, REDUCES TUMOR HYPOXIA AND DRAMATICALLY ENHANCES RADIATION THERAPY IN INTRACRANIAL MODELS OF GLIOBLASTOMA
inferredcites →https://doi.org/10.1097/00005072-199806000-00002openalex-snapshot
Sustained Hypoxia-Ischemia Results in Reactive Nitrogen and Oxygen Species Production and Injury in the Premature Fetal Rabbit Brain
inferredcites →https://doi.org/10.1097/cji.0b013e3181eec14copenalex-snapshot
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
inferredcites →https://doi.org/10.1101/sqb.2011.76.012856openalex-snapshot
Cancer Cell Metabolism
inferredcites →https://doi.org/10.1111/j.1349-7006.2012.02259.xopenalex-snapshot
Chemokine C ‐ C motif receptor 5 and C ‐ C motif ligand 5 promote cancer cell migration under hypoxia
inferredcites →https://doi.org/10.1111/j.1365-2249.2011.04515.xopenalex-snapshot
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
inferredcites →https://doi.org/10.1111/j.1399-0039.2009.01401.xopenalex-snapshot
Immune surveillance of human cancer: if the cytotoxic T‐lymphocytes play the music, does the tumoral system call the tune?
inferredcites →https://doi.org/10.1113/jphysiol.2004.081893openalex-snapshot
Hypoxia modulates early events in T cell receptor‐mediated activation in human T lymphocytes via Kv1.3 channels
inferredcites →https://doi.org/10.1126/science.aaa4971openalex-snapshot
Neoantigens in cancer immunotherapy
inferredcites →https://doi.org/10.1126/scitranslmed.aaa1260openalex-snapshot
Immunological mechanisms of the antitumor effects of supplemental oxygenation
inferredcites →https://doi.org/10.1152/ajpcell.00207.2015openalex-snapshot
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
inferredcites →https://doi.org/10.1158/0008-5472.can-05-3204openalex-snapshot
Cannibalism of Live Lymphocytes by Human Metastatic but Not Primary Melanoma Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-09-4672openalex-snapshot
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
inferredcites →https://doi.org/10.1158/0008-5472.can-10-1439openalex-snapshot
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
inferredcites →https://doi.org/10.1158/0008-5472.can-11-1094openalex-snapshot
Blocking Hypoxia-Induced Autophagy in Tumors Restores Cytotoxic T-Cell Activity and Promotes Regression
inferredcites →https://doi.org/10.1158/0008-5472.can-11-2449openalex-snapshot
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
inferredcites →https://doi.org/10.1158/0008-5472.can-11-3873openalex-snapshot
Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
inferredcites →https://doi.org/10.1158/0008-5472.can-12-1383openalex-snapshot
Hypoxia-Inducible miR-210 Regulates the Susceptibility of Tumor Cells to Lysis by Cytotoxic T Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-13-0992openalex-snapshot
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-14-0303openalex-snapshot
ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
inferredcites →https://doi.org/10.1158/2159-8290.cd-11-0314openalex-snapshot
The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
inferredcites →https://doi.org/10.1159/000455014openalex-snapshot
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
inferredcites →https://doi.org/10.1182/blood-2006-07-035972openalex-snapshot
Inhibitory effect of tumor cell–derived lactic acid on human T cells
inferredcites →https://doi.org/10.1182/blood-2008-03-143990openalex-snapshot
Damage control by hypoxia-inhibited AK
inferredcites →https://doi.org/10.1189/jlb.69.4.522openalex-snapshot
The effects of extracellular pH on immune function
inferredcites →https://doi.org/10.1371/journal.pbio.0030174openalex-snapshot
Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung Injury
inferredcites →https://doi.org/10.1371/journal.pone.0000853openalex-snapshot
Targeted Deletion of HIF-1α Gene in T Cells Prevents their Inhibition in Hypoxic Inflamed Tissues and Improves Septic Mice Survival
inferredcites →https://doi.org/10.1371/journal.pone.0064835openalex-snapshot
Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
inferredcites →https://doi.org/10.1615/critrevimmunol.v31.i5.10openalex-snapshot
Microenvironmental Hypoxia Orchestrating the Cell Stroma Cross Talk, Tumor Progression and Antitumor Response
inferredcites →https://doi.org/10.1681/asn.2014121248openalex-snapshot
Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury
inferredcites →https://doi.org/10.1684/bdc.2010.1295openalex-snapshot
Cytotoxic T cells – Stroma interactions
inferredcites →https://doi.org/10.18632/oncoscience.226openalex-snapshot
EMT in immuno-resistance
inferredcites →https://doi.org/10.18632/oncotarget.4564openalex-snapshot
HIF2a inhibitors for the treatment of VHL disease
inferredcites →https://doi.org/10.2174/138161209789649402openalex-snapshot
HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
inferredcites →https://doi.org/10.2741/2692openalex-snapshot
Macrophage activation and polarization
inferredcites →https://doi.org/10.3389/fimmu.2011.00027openalex-snapshot
In vivo T Cell Activation in Lymphoid Tissues is Inhibited in the Oxygen-Poor Microenvironment
inferredcites →https://doi.org/10.3389/fonc.2013.00154openalex-snapshot
The Tumor Microenvironment and Strategies to Improve Drug Distribution
inferredcites →https://doi.org/10.3389/fonc.2013.00231openalex-snapshot
Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
inferredcites →https://doi.org/10.3892/ijo.2012.1630openalex-snapshot
Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner
inferredcites →https://doi.org/10.3892/ijo.32.3.527openalex-snapshot
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)
inferredcites →https://doi.org/10.4049/jimmunol.1003251openalex-snapshot
IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer
inferredcites →https://doi.org/10.4049/jimmunol.1302140openalex-snapshot
Cutting Edge: Hypoxia-Induced Nanog Favors the Intratumoral Infiltration of Regulatory T Cells and Macrophages via Direct Regulation of TGF-β1
inferredcites →https://doi.org/10.4049/jimmunol.147.10.3638openalex-snapshot
Comparative studies of the cytotoxic T lymphocyte-mediated cytotoxicity and of extracellular ATP-induced cell lysis. Different requirements in extracellular Mg2+ and pH
inferredcites →https://doi.org/10.4049/jimmunol.167.11.6140openalex-snapshot
Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions
inferredcites →https://doi.org/10.4049/jimmunol.168.11.5900openalex-snapshot
HER-2/ neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy
inferredcites →https://doi.org/10.4049/jimmunol.174.12.7592openalex-snapshot
TCR Engagement Increases Hypoxia-Inducible Factor-1α Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells
inferredcites →https://doi.org/10.4049/jimmunol.177.10.6780openalex-snapshot
T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5′-Adenosine Monophosphate to Adenosine
inferredcites →https://doi.org/10.4049/jimmunol.177.8.4962openalex-snapshot
Cutting Edge: Hypoxia-Inducible Factor 1α and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes
inferredcites →https://doi.org/10.4161/21624011.2014.954463openalex-snapshot
Targeting hypoxia at the forefront of anticancer immune responses
inferredcites →https://doi.org/10.4161/2162402x.2014.985951openalex-snapshot
HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysis
inferredcites →https://doi.org/10.4161/auto.19572openalex-snapshot
Hypoxia-induced autophagy
inferredcites →https://doi.org/10.4161/auto.26924openalex-snapshot
Autophagic degradation of GZMB/granzyme B
inferredcites →https://doi.org/10.4161/cbt.9.12.12347openalex-snapshot
Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics
inferredcites →https://doi.org/10.4161/onci.22355openalex-snapshot
Hypoxia-driven immunosuppression contributes to the pre-metastatic niche

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4764081openalex-extracted
Photothermal Probiotics Delivery of Photodynamic Agents for Enhanced Immunogenic Cell Death Within Hypoxia Center of Solid Tumors
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm082.pub2openalex-snapshot
Malignant Tumors of the Adrenal Gland
inferred← citeshttps://doi.org/10.1002/adbi.201900236openalex-snapshot
Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/adfm.202314012openalex-snapshot
Metal–Organic Framework Nanocomposites in Conquering Hypoxia for Tumor Therapy
inferred← citeshttps://doi.org/10.1002/adhm.202000064openalex-snapshot
Multifunctional STING‐Activating Mn3O4@Au‐dsDNA/DOX Nanoparticle for Antitumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.202513609openalex-snapshot
Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics
inferred← citeshttps://doi.org/10.1002/adtp.202000218openalex-snapshot
Tuning Nanosiliceous Framework for Enhanced Cancer Theranostic Applications
inferred← citeshttps://doi.org/10.1002/ajh.25099openalex-snapshot
CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion
inferred← citeshttps://doi.org/10.1002/asia.201801826openalex-snapshot
Hypoxia‐Activated Prodrugs of PERK Inhibitors
inferred← citeshttps://doi.org/10.1002/biot.201900438openalex-snapshot
Emerging Strategies in Anticancer Combination Therapy Employing Silica‐Based Nanosystems
inferred← citeshttps://doi.org/10.1002/btm2.70126openalex-snapshot
Engineering the tumor immune landscape: Translating non‐invasive physical stimulation into tumor‐associated macrophage‐targeted cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/cam4.4126openalex-snapshot
Hypoxia‐related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD‐L1 squamous and adenocarcinoma NSCLC
inferred← citeshttps://doi.org/10.1002/cncr.70223openalex-snapshot
Magnetic resonance‐guided split‐course hypo‐fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non–small cell lung cancer: A single arm, phase 2 study
inferred← citeshttps://doi.org/10.1002/ijc.32889openalex-snapshot
Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination
inferred← citeshttps://doi.org/10.1002/inmd.20230002openalex-snapshot
Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies
inferred← citeshttps://doi.org/10.1002/iub.2619openalex-snapshot
Targeting DNA topoisomerase IIα ( TOP2A ) in the hypoxic tumour microenvironment using unidirectional hypoxia‐activated prodrugs ( uHAPs )
inferred← citeshttps://doi.org/10.1002/jbt.22585openalex-snapshot
Retracted: Identification and validation of hypoxic markers of glioblastoma multiforme in methylation, somatic CNV characteristics based on large‐scale samples
inferred← citeshttps://doi.org/10.1002/jcp.30575openalex-snapshot
Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities
inferred← citeshttps://doi.org/10.1002/mco2.176openalex-snapshot
Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
inferred← citeshttps://doi.org/10.1002/mco2.203openalex-snapshot
Hypoxia signaling in cancer: Implications for therapeutic interventions
inferred← citeshttps://doi.org/10.1002/path.5402openalex-snapshot
Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue‐based research
inferred← citeshttps://doi.org/10.1002/pros.23802openalex-snapshot
Optimizing live‐animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID‐NSG mice
inferred← citeshttps://doi.org/10.1002/psc.3561openalex-snapshot
Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
inferred← citeshttps://doi.org/10.1002/smll.201801120openalex-snapshot
A Multifunctional Biomimetic Nanoplatform for Relieving Hypoxia to Enhance Chemotherapy and Inhibit the PD‐1/PD‐L1 Axis
inferred← citeshttps://doi.org/10.1002/smll.202003000openalex-snapshot
Retooling Cancer Nanotherapeutics’ Entry into Tumors to Alleviate Tumoral Hypoxia
inferred← citeshttps://doi.org/10.1007/16833_2024_337openalex-snapshot
Bacteria-Based Approach to Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-3-030-34461-0_18openalex-snapshot
Hypoxia Compromises Anti-Cancer Immune Responses
inferred← citeshttps://doi.org/10.1007/978-3-031-07634-3_5openalex-snapshot
Autophagy in Cancer: A Metabolic Perspective
inferred← citeshttps://doi.org/10.1007/978-3-031-74842-4_3openalex-snapshot
Hypoxia, Stem Cells and Cancer Stem Cells
inferred← citeshttps://doi.org/10.1007/978-3-032-23814-6_10openalex-snapshot
Anti-inflammatory Bioactive Compounds for Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-3-319-78762-6_15openalex-snapshot
The Clinical Impact of Hypoxia in Head and Neck Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-319-91287-5_27openalex-snapshot
Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression
inferred← citeshttps://doi.org/10.1007/978-981-10-4499-1_1openalex-snapshot
Microenvironment Cytometry
inferred← citeshttps://doi.org/10.1007/978-981-15-4501-6_51-1openalex-snapshot
Hypoxic Stress Perturb DNA Repair Mechanisms Leading to Genetic Instability
inferred← citeshttps://doi.org/10.1007/978-981-15-9411-3_51openalex-snapshot
Hypoxic Stress Perturb DNA Repair Mechanisms Leading to Genetic Instability
inferred← citeshttps://doi.org/10.1007/978-981-99-3978-7_2openalex-snapshot
Radiobiology of Stereotactic Ablative Radiation Therapy
inferred← citeshttps://doi.org/10.1007/s00018-020-03581-0openalex-snapshot
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
inferred← citeshttps://doi.org/10.1007/s00280-021-04320-3openalex-snapshot
Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug
inferred← citeshttps://doi.org/10.1007/s00432-019-03080-1openalex-snapshot
Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance
inferred← citeshttps://doi.org/10.1007/s10147-023-02436-5openalex-snapshot
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy
inferred← citeshttps://doi.org/10.1007/s10555-021-10009-zopenalex-snapshot
Model systems in SDHx-related pheochromocytoma/paraganglioma
inferred← citeshttps://doi.org/10.1007/s10555-023-10123-0openalex-snapshot
Is cancer an intelligent species?
inferred← citeshttps://doi.org/10.1007/s10787-026-02219-0openalex-snapshot
Flavonoids and semi-synthetic derivatives targeting oncogenic inflammation: dose-response relationships, toxicological profiles, and synergistic potential
inferred← citeshttps://doi.org/10.1007/s11095-020-02892-yopenalex-snapshot
RETRACTED ARTICLE: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
inferred← citeshttps://doi.org/10.1007/s11523-018-0555-4openalex-snapshot
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
inferred← citeshttps://doi.org/10.1007/s11864-020-00787-zopenalex-snapshot
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
inferred← citeshttps://doi.org/10.1007/s12033-023-00807-xopenalex-snapshot
A Novel Pancreatic Cancer Hypoxia Status Related Gene Signature for Prognosis and Therapeutic Responses
inferred← citeshttps://doi.org/10.1007/s12094-023-03281-8openalex-snapshot
Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey
inferred← citeshttps://doi.org/10.1007/s12274-023-5698-7openalex-snapshot
Synthesis of fluorinated CaCO3-based oxygen-supplying nanophotosensitizers to potentiate photodynamic immunotherapy by reversing tumor hypoxia and immunosuppression
inferred← citeshttps://doi.org/10.1007/s43032-026-02060-4openalex-snapshot
The Model Related to Hypoxia and Endoplasmic Reticulum Stress Predicting Prognosis and Immunotherapy Response in Uterine Corpus Endometrial Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00028-1openalex-snapshot
Translational Pharmacology and Clinical Trials
inferred← citeshttps://doi.org/10.1016/b978-0-12-822620-9.00011-2openalex-snapshot
Reversing the NK inhibitory tumor microenvironment by targeting suppressive immune effectors
inferred← citeshttps://doi.org/10.1016/b978-0-323-66181-2.00012-3openalex-snapshot
CAR T-Cell Therapy for CNS Malignancies
inferred← citeshttps://doi.org/10.1016/b978-0-443-27731-3.00012-7openalex-snapshot
The future of cancer immunotherapy: Combining gene and cellular approaches
inferred← citeshttps://doi.org/10.1016/b978-0-443-33910-3.00005-4openalex-snapshot
Hindrance in immunotherapy resistant glioblastoma
inferred← citeshttps://doi.org/10.1016/bs.acr.2023.03.002openalex-snapshot
Lnc-ing epigenetic mechanisms with autophagy and cancer drug resistance
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2024.07.003openalex-snapshot
Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells
inferred← citeshttps://doi.org/10.1016/j.actbio.2020.01.012openalex-snapshot
Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.actbio.2021.02.030openalex-snapshot
Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
inferred← citeshttps://doi.org/10.1016/j.actbio.2023.12.012openalex-snapshot
Current trends in gas-synergized phototherapy for improved antitumor theranostics
inferred← citeshttps://doi.org/10.1016/j.addr.2021.03.015openalex-snapshot
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
inferred← citeshttps://doi.org/10.1016/j.addr.2021.05.001openalex-snapshot
Hot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models
inferred← citeshttps://doi.org/10.1016/j.addr.2025.115577openalex-snapshot
Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology
inferred← citeshttps://doi.org/10.1016/j.addr.2025.115757openalex-snapshot
Engineering tumor spatial heterogeneity in vitro
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104989openalex-snapshot
Metabolic regulation of the HBV-specific T cell function
inferred← citeshttps://doi.org/10.1016/j.apsb.2020.01.004openalex-snapshot
Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development
inferred← citeshttps://doi.org/10.1016/j.apsb.2020.09.014openalex-snapshot
Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment
inferred← citeshttps://doi.org/10.1016/j.bbadis.2021.166258openalex-snapshot
Connexin channels modulation in pathophysiology and treatment of immune and inflammatory disorders
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2025.120013openalex-snapshot
Are connexin hemichannels playing any role in cancer?
inferred← citeshttps://doi.org/10.1016/j.bbcan.2018.07.002openalex-snapshot
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
inferred← citeshttps://doi.org/10.1016/j.bbcan.2022.188826openalex-snapshot
The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate
inferred← citeshttps://doi.org/10.1016/j.bcp.2018.08.027openalex-snapshot
Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects
inferred← citeshttps://doi.org/10.1016/j.beem.2019.101354openalex-snapshot
Metastatic pheochromocytoma and paraganglioma: Management of endocrine manifestations, surgery and ablative procedures, and systemic therapies
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2022.05.022openalex-snapshot
Oxygen microcapsules improve immune checkpoint blockade by ameliorating hypoxia condition in pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2018.05.051openalex-snapshot
Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2019.119578openalex-snapshot
Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2023.122090openalex-snapshot
Mesocrystalline ZnS nanoparticles-augmented sonocatalytic full water splitting into H2/O2 for immunoactivating deep tumor
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2024.122481openalex-snapshot
Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113068openalex-snapshot
Hypoxia, a key factor in the immune microenvironment
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115622openalex-snapshot
Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells
inferred← citeshttps://doi.org/10.1016/j.bmc.2018.04.001openalex-snapshot
Screening of ligands for redox-active europium using magnetic resonance imaging
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.03.020openalex-snapshot
Reactive oxygen species and cancer: A complex interaction
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.04.017openalex-snapshot
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.05.021openalex-snapshot
Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints
inferred← citeshttps://doi.org/10.1016/j.canlet.2022.01.012openalex-snapshot
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.canlet.2023.216236openalex-snapshot
Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment
inferred← citeshttps://doi.org/10.1016/j.cbpa.2021.05.010openalex-snapshot
Recent advances in intravital microscopy for preclinical research
inferred← citeshttps://doi.org/10.1016/j.cclet.2024.109957openalex-snapshot
Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding
inferred← citeshttps://doi.org/10.1016/j.cclet.2026.112644openalex-snapshot
Engineered functional nanotherapeutics for remodeling hypoxia in the tumor microenvironment: Toward enhanced cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2024.216109openalex-snapshot
Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application
inferred← citeshttps://doi.org/10.1016/j.cej.2022.135310openalex-snapshot
Turning Fluvastatin into a supramolecular immuno-sensitizer towards augmented tumor immunotherapy
inferred← citeshttps://doi.org/10.1016/j.cej.2025.161208openalex-snapshot
Engineering microcapsules with immune modulatory properties: Applications in cancer, inflammation, and autoimmunity
inferred← citeshttps://doi.org/10.1016/j.celrep.2017.08.071openalex-snapshot
Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
inferred← citeshttps://doi.org/10.1016/j.chembiol.2021.04.004openalex-snapshot
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor
inferred← citeshttps://doi.org/10.1016/j.clon.2019.02.004openalex-snapshot
Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2024.104309openalex-snapshot
Clinical characteristics associated with efficacy and prognosis among patients treated with PD-1/PD-L1 inhibitors for early-stage triple-negative breast cancers: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ebiom.2019.09.037openalex-snapshot
Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia
inferred← citeshttps://doi.org/10.1016/j.ejca.2020.08.026openalex-snapshot
Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.01.039openalex-snapshot
Lost in application: Measuring hypoxia for radiotherapy optimisation
inferred← citeshttps://doi.org/10.1016/j.eprac.2022.10.002openalex-snapshot
Paraganglioma of the Head and Neck: A Review
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2017.10.385openalex-snapshot
Antagonism in effectiveness of evofosfamide and doxorubicin through intermolecular electron transfer
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2020.10.304openalex-snapshot
Modeling the photodynamic effect in 2D versus 3D cell culture under normoxic and hypoxic conditions
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2022.12.051openalex-snapshot
Injectable Oxygen Microparticles Boost Radiation–Mediated In Situ Vaccination and Systemic Antitumor Immune Responses
inferred← citeshttps://doi.org/10.1016/j.jare.2023.02.005openalex-snapshot
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.06.001openalex-snapshot
A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.09.029openalex-snapshot
Reshaping hypoxia and silencing CD73 via biomimetic gelatin nanotherapeutics to boost immunotherapy
inferred← citeshttps://doi.org/10.1016/j.jconrel.2023.03.026openalex-snapshot
HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy
inferred← citeshttps://doi.org/10.1016/j.labinv.2023.100210openalex-snapshot
PD-L1 Expression is Linked to Tumor-Infiltrating T-Cell Exhaustion and Adverse Pathological Behavior in Pheochromocytoma/Paraganglioma
inferred← citeshttps://doi.org/10.1016/j.lpm.2019.02.031openalex-snapshot
Pancreatic cancer – What's next?
inferred← citeshttps://doi.org/10.1016/j.lungcan.2019.01.004openalex-snapshot
PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data
inferred← citeshttps://doi.org/10.1016/j.mam.2026.101486openalex-snapshot
Unravelling the mystery of hypoxia-induced miRNAs in breast cancer: A molecular cross-talk driving tumour progression and therapy resistance
inferred← citeshttps://doi.org/10.1016/j.mtbio.2026.102875openalex-snapshot
Oxygen-carrying nanovaccine potentiates cancer immunotherapy for heterogeneous solid tumors
inferred← citeshttps://doi.org/10.1016/j.nantod.2020.100920openalex-snapshot
Metal-organic frameworks-based nanozymes for combined cancer therapy
inferred← citeshttps://doi.org/10.1016/j.neo.2018.11.009openalex-snapshot
An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2024.108918openalex-snapshot
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response
inferred← citeshttps://doi.org/10.1016/j.omto.2021.06.011openalex-snapshot
Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
inferred← citeshttps://doi.org/10.1016/j.phrs.2019.104353openalex-snapshot
Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.prp.2024.155370openalex-snapshot
The tumor microenvironment’s in pancreatic cancer: Effects on immunotherapy success and novel strategies to overcome the hostile environment
inferred← citeshttps://doi.org/10.1016/j.redox.2023.102766openalex-snapshot
Tumor-localized catalases can fail to alter tumor growth and transcriptional profiles in subcutaneous syngeneic mouse tumor models
inferred← citeshttps://doi.org/10.1016/j.scr.2021.102630openalex-snapshot
Hypoxia induction of SH2D3A triggers malignant progression of lung cancer
inferred← citeshttps://doi.org/10.1016/j.semcancer.2017.03.001openalex-snapshot
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
inferred← citeshttps://doi.org/10.1016/j.semcancer.2020.01.003openalex-snapshot
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.semcancer.2020.01.009openalex-snapshot
Tumor hypermetabolism confers resistance to immunotherapy
inferred← citeshttps://doi.org/10.1016/j.semcancer.2023.09.002openalex-snapshot
Targeting intratumoral hypoxia to enhance anti-tumor immunity
inferred← citeshttps://doi.org/10.1016/j.tcb.2021.02.005openalex-snapshot
Peroxisomes as cellular adaptors to metabolic and environmental stress
inferred← citeshttps://doi.org/10.1016/j.tibs.2018.09.004openalex-snapshot
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1016/j.tips.2017.05.002openalex-snapshot
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
inferred← citeshttps://doi.org/10.1016/j.trecan.2017.09.006openalex-snapshot
Migrating into the Tumor: a Roadmap for T Cells
inferred← citeshttps://doi.org/10.1016/j.trecan.2019.09.001openalex-snapshot
Metabolic Stress Triggers Immune Escape by Tumors
inferred← citeshttps://doi.org/10.1016/j.trecan.2022.06.002openalex-snapshot
Vascular damage in tumors: a key player in stereotactic radiation therapy?
inferred← citeshttps://doi.org/10.1016/j.trecan.2022.12.008openalex-snapshot
T cell exhaustion in malignant gliomas
inferred← citeshttps://doi.org/10.1016/j.ymthe.2019.07.011openalex-snapshot
Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7
inferred← citeshttps://doi.org/10.1021/acs.biomac.4c00597openalex-snapshot
Injectable Dendrimer Hydrogel Delivers Melphalan in Both Conjugated and Free Forms for Retinoblastoma
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b01678openalex-snapshot
Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.3c00846openalex-snapshot
Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1021/acs.nanolett.3c02061openalex-snapshot
Deep Tumor Penetration of CRISPR-Cas System for Photothermal-Sensitized Immunotherapy via Probiotics
inferred← citeshttps://doi.org/10.1021/acsabm.0c00042openalex-snapshot
Tumor Microenvironment-Responsive and Catalytic Cascade-Enhanced Nanocomposite for Tumor Thermal Ablation Synergizing with Chemodynamic and Chemotherapy
inferred← citeshttps://doi.org/10.1021/acsabm.0c01286openalex-snapshot
Engineering Living Bacteria for Cancer Therapy
inferred← citeshttps://doi.org/10.1021/acsami.9b19585openalex-snapshot
Fe3+-Coordinated Multifunctional Elastic Nanoplatform for Effective in Vivo Gene Transfection
inferred← citeshttps://doi.org/10.1021/acsnano.2c07286openalex-snapshot
Recent Progress and Trends in X-ray-Induced Photodynamic Therapy with Low Radiation Doses
inferred← citeshttps://doi.org/10.1021/acsnano.3c07763openalex-snapshot
Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
inferred← citeshttps://doi.org/10.1021/acsnano.8b04371openalex-snapshot
Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal Effect
inferred← citeshttps://doi.org/10.1021/acsnanomed.5c00021openalex-snapshot
Turning Tumor Acidosis into a Therapeutic Advantage with Nanomedicine
inferred← citeshttps://doi.org/10.1038/s41368-021-00131-7openalex-snapshot
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
inferred← citeshttps://doi.org/10.1038/s41388-021-01846-xopenalex-snapshot
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
inferred← citeshttps://doi.org/10.1038/s41389-019-0135-1openalex-snapshot
Hypomethylation at non-CpG/CpG sites in the promoter of HIF-1α gene combined with enhanced H3K9Ac modification contribute to maintain higher HIF-1α expression in breast cancer
inferred← citeshttps://doi.org/10.1038/s41392-023-01332-8openalex-snapshot
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
inferred← citeshttps://doi.org/10.1038/s41401-020-0423-5openalex-snapshot
Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells
inferred← citeshttps://doi.org/10.1038/s41416-025-02975-wopenalex-snapshot
Hypoxic tumor cell line lysate-pulsed dendritic cell vaccine exhibits better therapeutic effects on hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41419-017-0061-0openalex-snapshot
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
inferred← citeshttps://doi.org/10.1038/s41423-021-00833-2openalex-snapshot
Microenvironmental influences on T cell immunity in cancer and inflammation
inferred← citeshttps://doi.org/10.1038/s41430-020-0683-7openalex-snapshot
Immunotherapy on acid: opportunities and challenges
inferred← citeshttps://doi.org/10.1038/s41467-021-24069-wopenalex-snapshot
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors
inferred← citeshttps://doi.org/10.1038/s41467-024-55575-2openalex-snapshot
Phthalocyanine aggregates as semiconductor-like photocatalysts for hypoxic-tumor photodynamic immunotherapy
inferred← citeshttps://doi.org/10.1038/s41551-024-01315-2openalex-snapshot
Microfluidic technologies for enhancing the potency, predictability and affordability of adoptive cell therapies
inferred← citeshttps://doi.org/10.1038/s41568-018-0070-zopenalex-snapshot
Tumour-targeting bacteria engineered to fight cancer
inferred← citeshttps://doi.org/10.1038/s41571-021-00496-yopenalex-snapshot
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
inferred← citeshttps://doi.org/10.1038/s41577-025-01187-wopenalex-snapshot
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
inferred← citeshttps://doi.org/10.1038/s41585-025-01092-wopenalex-snapshot
The hypoxic ECM and neutrophils in MIBC immunotherapy resistance
inferred← citeshttps://doi.org/10.1038/s42254-025-00881-xopenalex-snapshot
Balancing innovation and safety in FLASH radiotherapy
inferred← citeshttps://doi.org/10.1039/c6mt00170jopenalex-snapshot
Autophagy and apoptosis: studies on the effects of bisthiosemicarbazone copper( ii ) complexes on p53 and p53-null tumour cell lines
inferred← citeshttps://doi.org/10.1039/c8nr07679kopenalex-snapshot
Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy
inferred← citeshttps://doi.org/10.1039/d0nr06271eopenalex-snapshot
Advanced nanomaterials for hypoxia tumor therapy: challenges and solutions
inferred← citeshttps://doi.org/10.1039/d1bm01127hopenalex-snapshot
Tumor microenvironment and nanotherapeutics: intruding the tumor fort
inferred← citeshttps://doi.org/10.1039/d1lc00603gopenalex-snapshot
Oxygen control: the often overlooked but essential piece to create better in vitro systems
inferred← citeshttps://doi.org/10.1039/d2bm00455kopenalex-snapshot
A phenolic based tumor-permeated nano-framework for immunogenic cell death induction combined with PD-L1 immune checkpoint blockade
inferred← citeshttps://doi.org/10.1039/d2ra02005jopenalex-snapshot
Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics
inferred← citeshttps://doi.org/10.1039/d3sc03635aopenalex-snapshot
Mn( iii )-mediated carbon-centered radicals generate an enhanced immunotherapeutic effect
inferred← citeshttps://doi.org/10.1039/d5pm00183hopenalex-snapshot
Cyclodextrin-based nanosponge co-delivery of doxorubicin and EMD: synergistic anticancer activity with improved selectivity toward cancer cells
inferred← citeshttps://doi.org/10.1049/syb2.12097openalex-snapshot
A tumour‐associated macrophage‐based signature for deciphering prognosis and immunotherapy response in prostate cancer
inferred← citeshttps://doi.org/10.1053/j.gastro.2022.11.029openalex-snapshot
Integrated Multi-Omics Landscape of Liver Metastases
inferred← citeshttps://doi.org/10.1073/pnas.2102166118openalex-snapshot
Multiparameter persistent homology landscapes identify immune cell spatial patterns in tumors
inferred← citeshttps://doi.org/10.1080/08830185.2017.1363199openalex-snapshot
Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy
inferred← citeshttps://doi.org/10.1080/09553002.2021.1988178openalex-snapshot
The importance of hypoxia in radiotherapy for the immune response, metastatic potential and FLASH-RT
inferred← citeshttps://doi.org/10.1080/14712598.2019.1608179openalex-snapshot
Facing the future: challenges and opportunities in adoptive T cell therapy in cancer
inferred← citeshttps://doi.org/10.1080/14712598.2022.2108701openalex-snapshot
Signaling new therapeutic opportunities: cytokines in prostate cancer
inferred← citeshttps://doi.org/10.1080/14737140.2020.1745634openalex-snapshot
Melanoma immunotherapy: strategies to overcome pharmacological resistance
inferred← citeshttps://doi.org/10.1080/14796694.2024.2342226openalex-snapshot
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma
inferred← citeshttps://doi.org/10.1080/2162402x.2016.1232236openalex-snapshot
Hypoxia and antitumor CD8+ T cells: An incompatible alliance?
inferred← citeshttps://doi.org/10.1080/2162402x.2019.1665976openalex-snapshot
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma
inferred← citeshttps://doi.org/10.1080/2162402x.2019.1674113openalex-snapshot
Prognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors
inferred← citeshttps://doi.org/10.1080/2162402x.2021.1968611openalex-snapshot
“Suffocating” tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy
inferred← citeshttps://doi.org/10.1080/2162402x.2021.1974233openalex-snapshot
Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity?
inferred← citeshttps://doi.org/10.1088/1361-6528/aa8d9copenalex-snapshot
Au@Pt nanoparticles as catalase mimics to attenuate tumor hypoxia and enhance immune cell-mediated cytotoxicity
inferred← citeshttps://doi.org/10.1088/1758-5090/abe6f2openalex-snapshot
Cell spheroids as a versatile research platform: formation mechanisms, high throughput production, characterization and applications
inferred← citeshttps://doi.org/10.1093/bfgp/elab035openalex-snapshot
Non-CpG methylation—a key epigenetic modification in cancer
inferred← citeshttps://doi.org/10.1093/nsr/nwad031openalex-snapshot
Programming the lifestyles of engineered bacteria for cancer therapy
inferred← citeshttps://doi.org/10.1097/cco.0000000000000589openalex-snapshot
Malignant pheochromocytoma and paraganglioma: management options
inferred← citeshttps://doi.org/10.1097/md.0000000000039184openalex-snapshot
Hypoxia-related signature to risk stratify patients for the benefit of immune checkpoint inhibitors therapy in head and neck squamous cell carcinoma: An experimental study
inferred← citeshttps://doi.org/10.1097/med.0000000000000330openalex-snapshot
Malignant pheochromocytoma–paraganglioma: pathogenesis, TNM staging, and current clinical trials
inferred← citeshttps://doi.org/10.1098/rsob.190262openalex-snapshot
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
inferred← citeshttps://doi.org/10.1101/2022.05.12.491632openalex-snapshot
Hypoxic memory of tumor intrinsic type I interferon suppression promotes breast cancer metastasis
inferred← citeshttps://doi.org/10.1101/2023.07.13.548899openalex-snapshot
An Engineered 3D Co-culture Model of Primary Macrophages and Patient-Derived Tumour Cells to Explore Cellular Responses in the Graded Hypoxic Microenvironment of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1101/2023.10.18.562926openalex-snapshot
Pathogenic CD8 T cell responses are driven by neutrophil-mediated hypoxia in cutaneous leishmaniasis
inferred← citeshttps://doi.org/10.1101/2024.06.26.600909openalex-snapshot
Elucidating the kinetic and thermodynamic insight into regulation of glycolysis by lactate dehydrogenase and its impact on tricarboxylic acid cycle and oxidative phosphorylation in cancer cells
inferred← citeshttps://doi.org/10.1101/2025.10.11.681845openalex-snapshot
Hypoxia Imaging as a Radiomics Signature in Tumors Using Novel 19 F-Eu-Based Contrast Agents for Magnetic Resonance Imaging
inferred← citeshttps://doi.org/10.1111/1754-9485.13416openalex-snapshot
Improving the synergistic combination of programmed death‐1/programmed death ligand‐1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment
inferred← citeshttps://doi.org/10.1111/cas.15602openalex-snapshot
Metformin and simvastatin synergistically suppress endothelin 1‐induced hypoxia and angiogenesis in multiple cancer types
inferred← citeshttps://doi.org/10.1111/cts.12856openalex-snapshot
Fundamentals of Cancer Immunology and Their Application to Cancer Vaccines
inferred← citeshttps://doi.org/10.1111/imm.12917openalex-snapshot
Hypoxia and acidosis: immune suppressors and therapeutic targets
showing the first 200 of 366 · page through all 366
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.